Intrathecal morphine therapy-related granulomas: faster to grow than thought

Vincent Jourdain1, Léo Cantin, Michel Prud'homme

  • 1Service de Neurochirurgie Fonctionnelle, Hôpital de l'Enfant-Jésus, Québec, Québec, Canada; Centre Hospitalier de l'Université de Sherbrooke, Sherbrooke, Québec, Canada.

Insights

Catheter-tip granulomas, a rare complication of intrathecal drug delivery, typically form over months. This case study highlights a granuloma developing unusually quickly, within 5 weeks of intrathecal morphine use.

Area of Science:

  • Neurology
  • Pain Management
  • Neurosurgery

Background:

  • Complications from intrathecal drug delivery systems are infrequent but can significantly impact patient outcomes.
  • Common complications include infections, skin erosion, and granulomas, with granulomas often presenting as sedation or reduced pain relief.
  • Granulomas are generally believed to develop gradually over several months.

Purpose of the Study:

  • To report a rare case of rapid catheter-tip granuloma formation following intrathecal morphine administration.
  • To discuss potential contributing factors for the accelerated development of this complication.

Main Methods:

  • Case report presentation.
  • Review of patient history and diagnostic findings related to intrathecal drug delivery.

Main Results:

  • A catheter-tip granuloma was diagnosed in a patient receiving intrathecal morphine via an implanted pump.
  • The granuloma formed significantly faster than typically observed, within 5 weeks of initiating morphine therapy.
  • The patient had been using the intrathecal pump for 3 months prior to diagnosis.

Conclusions:

  • Catheter-tip granulomas can form more rapidly than previously thought.
  • Early recognition and investigation of symptoms like sedation or decreased analgesia are crucial in patients with intrathecal drug delivery systems.
  • Further research into the pathogenesis of accelerated granuloma formation is warranted.

Related Concept Videos